Literature DB >> 11858882

Vulvar vestibulitis syndrome: an overview of non-surgical treatment.

L Mariani1.   

Abstract

Vulvar vestibulitis syndrome, which represents one of the major cause of dyspareunia, is a puzzling clinical entity. Although many treatment options have been employed, a rationale therapeutic strategy is still not stated. The present article reviews the most popular medical approaches of such entity (biofeedback, tricyclic antidepressants, interferon psychologic-behavioural therapy, diet modification), as well as those to avoid. Tricyclic antidepressants and biofeedback of the pelvic floor muscles represents the first line effective therapy. Moreover, psychological counselling must support any treatment options.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858882     DOI: 10.1016/s0301-2115(01)00526-7

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

Review 1.  Immunological and genetic characterization of women with vulvodynia.

Authors:  Stefan Gerber; Steven S Witkin; David Stucki
Journal:  J Med Life       Date:  2008 Oct-Dec

Review 2.  The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain : A systematic review.

Authors:  Barbara Wagner; Margarete Steiner; Dominikus Franz Xaver Huber; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2021-03-22       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.